CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Public ClinicalTrials.gov record NCT04206436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study is looking at the effects of cystic fibrosis treatment on bone muscle.
Study identification
- NCT ID
- NCT04206436
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2019
- Primary completion
- Dec 30, 2027
- Completion
- Dec 30, 2027
- Last update posted
- Oct 1, 2025
2019 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202-5149 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Bone Loss trials
Other public records listing Bone Loss. Sorted by last update posted; newest first. Not a recommendation.
- NCT04670965: Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis Not yet recruiting
- NCT05303636: LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women Active, not recruiting
- NCT04922333: Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery Recruiting
- NCT04954664: Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor Recruiting
- NCT05764733: Bone, Exercise, Alendronate, and Caloric Restriction Recruiting
- NCT04964466: Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04206436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2025 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04206436 live on ClinicalTrials.gov.